Proliferative Vitreoretinopathy (PVR)

  • H. MacKenzie Freeman
  • Felipe I. Tolentino

Table of contents

  1. Front Matter
    Pages i-xx
  2. Proliferative Vitreoretinopathy (PVR): An Update

    1. Front Matter
      Pages 1-1
    2. Carl Claes, H. MacKenzie Freeman, Felipe I. Tolentino
      Pages 3-11
    3. Bert M. Glaser
      Pages 12-21
    4. H. MacKenzie Freeman, Susan G. Elner, Felipe I. Tolentino, Charles L. Schepens, Victor M. Elner, Daniel M. Albert
      Pages 22-33
    5. Susan G. Elner, Victor M. Elner, Roberto Díaz-Rohena, H. MacKenzie Freeman, Felipe I. Tolentino, Daniel M. Albert
      Pages 34-45
    6. Felipe I. Tolentino, H. MacKenzie Freeman
      Pages 46-53
    7. Stanley Chang, Harvey Lincoff, Emin Ozmert, Dov Weinberger, Peter J. G. Maris
      Pages 54-59
    8. Anne M. Hanneken, Ronald G. Michels
      Pages 60-69
    9. Brooks W. McCuen II, Eugene de Juan Jr., Robert Machemer
      Pages 70-75
    10. Relja Živojnović, Diane A. E. Mertens, Ed Peperkamp, Sima Pavlović, Houdijn W. Beekhuis, Riel van Rij et al.
      Pages 76-80
    11. Mark S. Blumenkranz, Michael K. Hartzer
      Pages 81-87
    12. Walter H. Stern, John S. Lean, The Silicone Study Group
      Pages 88-96
  3. A Discussion of Common Concerns

    1. Front Matter
      Pages 97-97
    2. Gary W. Abrams, Steven T. Charles, William H. Havener, Robert Machemer, Charles L. Schepens, Walter H. Stern
      Pages 97-102
  4. PVR: Reports of Current Clinical and Research Studies

    1. Front Matter
      Pages 103-103
    2. Alexander R. Irvine, George F. Hilton, Lawrence I. Lonn, Ariah Schwartz, The Silicone Study Group
      Pages 105-109
    3. R. Sloan Wilson, David V. Poer, James H. Landers
      Pages 110-116
    4. Norman P. Blair
      Pages 117-123
    5. Brian C. Joondeph, Gholam A. Peyman, Bahram Khoobehi
      Pages 130-133
    6. Lory C. Snady-McCoy, Sheldon M. Buzney, Salim A. Bishara, Michael William Gaynon
      Pages 134-139
    7. Paul Sternberg Jr., Travis A. Meredith, Janet N. Hartmann, Ian R. Crocker
      Pages 140-144
    8. Norman D. Radtke, Michael T. Tseng, Kang-Nian Liu, Louise C. Moorhead
      Pages 145-149
    9. Jason S. Slakter, Yale L. Fisher, Jeffrey L. Shakin, John A. Sorenson, Donald M. Shafer
      Pages 150-155
    10. Mark E. Hammer, Deborah F. Rinder, E. Lynn Hicks, Chang-Hsu Yang, Carlton A. Hornung
      Pages 156-161
    11. Felipe I. Tolentino, Victorio N. Cajita, Hum Chung, Norio Ueno, Miguel F. Refojo
      Pages 162-165
    12. William L. Hutton, Dwain G. Fuller, William B. Snyder
      Pages 166-168
    13. Felipe I. Tolentino, Victorio N. Cajita, Hum Chung, Jaime Acosta, H. MacKenzie Freeman, Miguel F. Refojo
      Pages 177-180
    14. Miguel F. Refojo, Hum Chung, Victorio N. Cajita, Felipe I. Tolentino
      Pages 181-184
    15. Hidenao Ideta, Michiko Ishikawa, Shunsuke Inouye, Yukio Yoshino
      Pages 185-188
  5. Back Matter
    Pages 193-197

About this book


The purpose of this book is to provide an update both on the present management of proliferative vitreoretinopathy (PVR) and on clinical and experimental research being done to control this disease. The book is divided into three parts. The first part deals with the current management of PVR. The Retina Society Classification of PVR is based in part on a gradation of severity from minimal to massive; therefore, this book attempts to correlate the management of PVR with its severity. The treatment of PVR of varying degrees of severity, from mild to the most severe form, is described by those authors with extensive experience with this spectrum of cases. Much progress has been made in the management of severe PVR as a result of vitreous injections, vitrectomy, periretinal membrane surgery, and retinal surgery. Authors in this book show that in mild and moderately severe PVR excellent results can be obtained with techniques that are less invasive and possibly less likely to stimulate further abnormal cellular proliferation. The new modalities for treatment of PVR are discussed by authors having extensive experience with them. The current status of pharmacological treatment and new concepts of the pathobiology of PVR are discussed. The second part of the book deals with questions frequently encountered in the management of PVR. These questions are answered by a panel of experts including Gary W. Abrams, Steven T. Charles, William H. Havener, Robert Machemer, Charles L. Schepens, and Walter H. Stern.


biology classification documentation fixation macrophages management migration necrosis pathobiology pharmacology research retina surgery trauma treatment

Editors and affiliations

  • H. MacKenzie Freeman
    • 1
    • 2
    • 3
  • Felipe I. Tolentino
    • 1
    • 2
    • 3
  1. 1.Harvard Medical SchoolBostonUSA
  2. 2.Massachusetts Eye and Ear InfirmaryBostonUSA
  3. 3.Ophthalmic Microsurgery LaboratoryEye Research Institute of Retina FoundationBostonUSA

Bibliographic information